Executive & Scientific Leadership
The leadership of Medical Bravo combines institutional healthcare management with elite academic and technical research.
Our executive board guides international expansion, regulatory compliance, and cross-border clinical operations across our localized entities. Simultaneously, our scientific core—composed of specialized medical doctors and computer vision engineers—pioneers the development of compliant, hospital-integrated diagnostic AI infrastructure.
Corporate Governance & International Operations
Our corporate governance framework ensures structural alignment, strict regulatory compliance, and seamless operational scaling across all international jurisdictions. This executive team coordinates our cross-border diagnostic pipelines, manages localized entity operations across Europe, the UK, and the US, and drives strategic integration with major public and private healthcare networks.
Dr. Edo Crnčević
Founder & Chairman
Dr. Edo Crnčević is the Founder and Chairman of Medical Bravo and Med AI Bravo. He brings deep experience in building digital healthcare operations, long-term hospital partnerships and scalable diagnostic service models across international markets.
His work focuses on connecting clinical delivery, operational execution and technology strategy into a platform capable of supporting the next generation of diagnostic infrastructure.
As Chairman, Dr. Crnčević leads Medical Bravo’s long-term strategic direction, positioning the company as a trusted infrastructure partner for hospitals, radiology groups, OEMs and healthcare technology ecosystems worldwide.
Prof. Sven Lončarić
CEO, Med AI Bravo d.o.o.
Prof. Sven Lončarić leads Med AI Bravo’s AI and research strategy, bringing internationally recognised expertise in medical image analysis, computer engineering and clinical AI development. He is a Professor of Computer Engineering at the University of Zagreb Faculty of Electrical Engineering and Computing and has been ranked among the world’s top 2% most influential scientists by Stanford University / Elsevier.
At Med AI Bravo, Prof. Lončarić is responsible for shaping the long-term AI roadmap and translating advanced research into clinically relevant, scalable and enterprise-ready diagnostic infrastructure for radiology.
Prim. Dr. Marko Slavica
Global Medical Director
Prim. Dr. Marko Slavica leads Medical Bravo’s clinical strategy, radiology validation and real-world workflow integration. As an experienced radiologist and clinical lead, he ensures that every Medical Bravo solution is grounded in clinical safety, diagnostic quality and practical value for radiologists and healthcare providers.
At Medical Bravo, he connects medical expertise, quality assurance, AI validation and daily radiology operations, helping build technology that supports clinicians, reduces workflow complexity and strengthens diagnostic decision-making.
Robert Brandner
Chief Executive Officer, Medical Bravo Inc.
Robert Brandner leads Medical Bravo’s United States strategy, bringing more than 25 years of healthcare technology, CIO/CISO and executive leadership experience. He has held senior leadership roles in healthcare organisations and technology startups, combining operational discipline with deep understanding of enterprise healthcare systems.
At Medical Bravo, Bob is focused on US market development, strategic partnerships, healthcare technology alignment and building a trusted bridge between Medical Bravo’s European platform and the American healthcare ecosystem.
Martin Wells
Chief Executive Officer, Medical Bravo Ltd.
Martin Wells leads Medical Bravo UK and supports the company’s strategic rollout across the UK healthcare market. With extensive experience in healthtech and previous senior leadership experience at Medica UK, he brings strong operational, commercial and
institutional knowledge of the UK radiology and healthcare environment.
His role is focused on building long-term partnerships, supporting UK market expansion and helping Medical Bravo deliver AI-enabled radiology infrastructure within established healthcare systems.
Tihomir Vančina
Chief Executive Officer, Medical Bravo d.o.o.
Tihomir Vančina leads Medical Bravo Croatia, bringing extensive executive healthcare leadership experience from the Croatian public hospital system. Before joining Medical Bravo, he served for many years as CEO of one of Croatia’s leading public hospitals, gaining deep expertise in hospital management, clinical operations, organisational leadership and healthcare system execution.
At Medical Bravo Croatia, he is responsible for strengthening local operations, institutional relationships and regional execution as part of the Group’s broader European diagnostic infrastructure strategy. His background in managing complex healthcare environments supports Medical Bravo’s ability to build reliable, scalable and clinically grounded radiology services across hospitals and healthcare networks.
Scientific & Clinical Innovation
The technological and clinical backbone of Medical Bravo is driven by a specialized cohort of medical doctors, machine learning researchers, and computer vision engineers. This division spearheads our medical AI validation frameworks, oversees peer-reviewed clinical testing, and ensures our advanced diagnostic software integrates securely and natively into existing hospital PACS and workflow systems.
Med AI Bravo
ENGINEERING
Prim. Dr. Marko Slavica
Global Medical Director
Prim. Dr. Marko Slavica leads Medical Bravo’s clinical strategy, radiology validation and real-world workflow integration. As an experienced radiologist and clinical lead, he ensures that every Medical Bravo solution is grounded in clinical safety, diagnostic quality and practical value for radiologists and healthcare providers.
At Medical Bravo, he connects medical expertise, quality assurance, AI validation and daily radiology operations, helping build technology that supports clinicians, reduces workflow complexity and strengthens diagnostic decision-making.
Dr. Duje Medak
Chief Technology Officer
Dr. Duje Medak leads Medical Bravo’s technology architecture, software development and infrastructure execution. With a strong background in software engineering and healthcare IT, he is responsible for turning AI models and clinical requirements into scalable, secure and operationally reliable systems.
His work focuses on building the technical foundation for Medical Bravo’s platform: backend infrastructure, workflow integration, system architecture and enterprise-ready deployment across complex healthcare environments.
Dr. Jakob Nemir
Scientific and Clinical Lead
Assoc. Prof. Dr. Jakob Nemir leads Medical Bravo’s clinical research activities, bringing senior medical expertise as a neurosurgeon and academic clinician. His role connects clinical science, research design and real-world medical validation, ensuring that Medical Bravo’s AI and diagnostic infrastructure development remains grounded in rigorous clinical evidence.
At Medical Bravo, he supports the translation of advanced technology into clinically meaningful solutions, with a focus on research quality, medical relevance and collaboration between clinicians, engineers and healthcare institutions.
Radiologist Core Team
Dr. Marko Slavica
Global Medical Director
- Dedicated team of 15 licensed, practicing Radiologists: Providing continuous, high-volume diagnostic reporting across international healthcare networks.
- Clinical & Quality Operations: Responsible for clinical requirements, validation, real-world workflow integration, and quality activities.
- Subspecialty Expertise: Advanced Neuroradiology and Neurointerventional specialists ensuring precision interpretation and guidance for complex neurological and cerebrovascular cases.
Al Engineering Core Team
Dr. Duje Medak
Chief Technology Officer
- Team of 15 AI PhD Engineers: Composed of elite machine learning and computer vision specialists driving core model development.
- Enterprise Infrastructure: Engineers secure, resilient, high-throughput deployment environments for global healthcare networks.
- Native System Integration: Develops zero-friction pipelines that securely interface with existing clinical PACS and hospital IT ecosystems.
